Literature DB >> 15998246

The S-thiolating activity of membrane gamma-glutamyltransferase: formation of cysteinyl-glycine mixed disulfides with cellular proteins and in the cell microenvironment.

Alessandro Corti1, Aldo Paolicchi, Maria Franzini, Silvia Dominici, Alessandro F Casini, Alfonso Pompella.   

Abstract

Previous studies have documented that activity of the plasma membrane enzyme gamma-glutamyltransferase (GGT) is accompanied by prooxidant processes, with production of reactive oxygen species and oxidation of cellular protein thiols. The present work was aimed to verify the occurrence and extent of S-thiolation mediated by GGT and characterize the molecular species involved in mixed disulfide formation. Experiments show that the cysteinyl-glycine (CG) originating from cellular GGT-mediated glutathione (GSH) metabolism can efficiently thiolate cellular proteins, as well as proteins present in the extracellular environment. With cells presenting high levels of GGT expression, basal levels of CG-containing protein mixed disulfides are detectable, in cellular proteins, as well as in proteins of the culture medium. Stimulation of GGT activity in these cells by administration of substrates results in an increase of CG mixed disulfide formation and a concomitant decrease of GSH-containing disulfides, likely due to GGT-dependent removal of GSH from the system. The findings reported suggest that binding of CG ("protein S-cysteylglycylation") may represent an as yet unrecognized function of membrane GGT, likely playing a regulatory role(s) in the cell and its surroundings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998246     DOI: 10.1089/ars.2005.7.911

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  8 in total

Review 1.  Glutathione and redox signaling in substance abuse.

Authors:  Joachim D Uys; Patrick J Mulholland; Danyelle M Townsend
Journal:  Biomed Pharmacother       Date:  2014-06-24       Impact factor: 6.529

2.  Are standard cell culture conditions adequate for human umbilical cord blood mesenchymal stem cells?

Authors:  Roberta Lamanna; Alessandro Corti; Mariacarla Iorio; Francesca Nocchi; Patrizia Urciuoli; Simone Lapi; Fabrizio Scatena; Maria Franzini; Renato Vanacore; Evelina Lorenzini; Vanna Fierabracci; Aldo Paolicchi
Journal:  Blood Transfus       Date:  2013-02-21       Impact factor: 3.443

Review 3.  S-glutathionylation: from molecular mechanisms to health outcomes.

Authors:  Ying Xiong; Joachim D Uys; Kenneth D Tew; Danyelle M Townsend
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

4.  Helicobacter, gamma-glutamyltransferase and cancer: further intriguing connections.

Authors:  Maria Franzini; Alessandro Corti; Vanna Fierabracci; Alfonso Pompella
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  Pleiotropic functions of glutathione S-transferase P.

Authors:  Jie Zhang; Christina Grek; Zhi-Wei Ye; Yefim Manevich; Kenneth D Tew; Danyelle M Townsend
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

6.  Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum.

Authors:  Alessandro Corti; Maria Franzini; Silvana Cianchetti; Gabriella Bergamini; Evelina Lorenzini; Paola Melotti; Aldo Paolicchi; Pierluigi Paggiaro; Alfonso Pompella
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

7.  Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial.

Authors:  V Seebacher; S Polterauer; C Grimm; J Rahhal; G Hofstetter; E-M Bauer; H Husslein; H Leipold; C Marth; A Reinthaller; N Concin
Journal:  Br J Cancer       Date:  2012-02-07       Impact factor: 7.640

8.  Glutathione levels modulation as a strategy in host-parasite interactions-insights for biology of cancer.

Authors:  Francesco Pennacchio; Antonio Masi; Alfonso Pompella
Journal:  Front Pharmacol       Date:  2014-08-05       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.